Global Mycotoxin Binders Market is expected to grow with the CAGR of 8.5% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.
Access full Report @ https://www.databridgemarketresearch.com/reports/global-mycotoxin-binders-market
Mycotoxin binders market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased various strategic developments owing to favourable market scenario.
The major players dealing in mycotoxin binders market are introducing strong range of product portfolio. This helped the company to maximize the sales with enhanced product portfolio. For instance,
- In February 2019, Phibro Animal Health Corporation launched its latest microbial drug Provia Prime which helps optimize the gut microbiome to enhance poultry safety, immunity and productivity. A stable microbiota can contribute to increased body weight, better feed efficiency and lower mortality levels and lesions from pathogenic agents such as clostridium perfringens, E, as well. This can contribute to safe microbioma throughout the growth of agricultural poultry development, coli and salmonella. This launch has increased the customer base of the company into the market.
Cargil., Incorporated is dominating players in the mycotoxin binders market, the other key players existing in the market are Phibro Animal Health Corporation, Perstorp Holding AB, Zoetis, ADM, BASF SE, Adisseo, Bayer AG, Alltech, Bayer AG, Alltech, Amlan International, Impextraco NV, Norel Animal Nutrition, Olmix Group, Micron Bio-Systems, Milwhite, Inc., NOVUS INTERNATIONAL, Kemin Industries, Inc., Trouw Nutrition USA, LLC, VETLINE, Anpario plc, Brenntag AG.
Cargil., Incorporated
Cargil., Incorporated, company headquartered in Minneapolis, U.S. and was founded in 1865. The company is engaged in the production and delivery of food, agriculture, nutrition and risk management services. Company product categories are animal nutrition, food & beverage, bio industrial, foodservice, agriculture, risk management, meat & poultry, industrial, beauty, pharmaceutical, transportation among which animal nutrition market focused category.
- In November 2013, Cargill, Incorporated. category Animal Nutrition, through its Provimi company, launched PROMOTE, a new global brand and feed additive range designed to help deliver the industry's most advanced and efficient feed additive technologies to animal farmers, feed suppliers and retailers. Feed additives play an increasingly important role in animal nutrition as livestock producers explore innovative approaches to increase efficiency, boost feed conversion and meet rising market demands. PROMOTE is a big move forward in the dedication of Cargill Animal Feed to represent consumers as a valued partner and center of creativity.
The company has wide presence across the globe such as in Africa, Asia-Pacific, Europe, Latin America, Middle East, North America.
Phibro Animal Health Corporation
Phibro Animal Health Corporation is headquartered in New Jersey, U.S, which was founded in 1974. The company is engaged in manufacturing of upstream, downstream and renewables businesses product with well-established trading capability. The company engaged in providing solution for beef cattle, swine, poultry, dairy cattle, aqua, mineral nutrition, and performance products
- In August 2019, Phibro Animal Health Corporation has confirmed the purchase of the company and properties of Osprey Biotechnology, Inc., an advanced agricultural materials producer and marketer. The purchase of the Osprey Company expands Phibro's nutrition goods line and creates fresh prospects in the fast-growing animal health market. Osprey manufacturers and retailers have the broad variety of products across a number of sectors and applications. This acquisition has enhanced the growth of the company in the market.
The company has global presence in North America, South America, Europe, Middle East and Africa, Asia-Pacific and generates its revenue from Prince Agri Products, Inc. (U.S.), OmniGen Research, LLC (U.S.), Phibro Animal Health Holdings, Inc. (U.S.), Phibro Animal Health de Argentina SRL (Argentina), Biotay S.A. (Argentina) among others.
Zoetis
Zoetis headquartered in New Jersey, U.S., founded in 1950. The company is engaged in the manufacturing of high-quality drugs, vaccinations and medical devices, complemented by bio-engineering, genetic research and precision livestock farming. The company offers brand categories are companion animals. The company deals in the business segment such as livestock, companion animal, contract manufacturing & human health out of which companion animal is market focussed category. Our market focuses on the product and service categories of the company are companion animals, farm animals, diagnostics, and genetics among which companion animals is market focussed category.
- In April 2020, In April, Zoetis announced the purchase of Value Livestock Analytics to improve its animal safety technologies around the beef producers' spectrum of treatment. The implementation of Efficiency Livestock Analytics, a technology company which simplifies data and animal-based study, will allow Zoetis to drive innovations in precision animal farms and increase producers' productivity.
The company has its presence in North America, Europe, Asia- Pacific, South America, Middle East and Africa. In addition to it, the company also generates its revenue from the various subsidiaries such as Alpharma (Bermuda) Investments Ltd. (Bermuda), Alpharma (Bermuda) Ltd. (Bermuda), Alpharma (Bermuda), LLC (United States), Alpharma (Luxembourg) S.A.R.L. y Compania Limitada (Chile), Alpharma (Luxembourg) S.àr.l. (Luxembourg) among others.
